U.S. Markets closed

Today's Research Reports on Trending Tickers: Amicus Therapeutics and ACADIA Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / January 28, 2019 / U.S. equities closed higher on Friday as companies continue to report upbeat earnings and Trump and the Democrats agreed to reopen the government until Feb. 15. The Dow Jones Industrial Average climbed 0.75 percent to settle at 24,737.20, while the S&P 500 jumped 0.85 percent to close at 2,664.76. The Nasdaq advanced 1.29 percent to settle at 7,164.86.

The Market Wealth Report Initiates Coverage on:

Amicus Therapeutics, Inc.
https://marketwealthreport.com/report/FOLD/

ACADIA Pharmaceuticals Inc.
https://marketwealthreport.com/report/ACAD/

Amicus Therapeutics' stock jumped 4.49% Friday, to close the day at $11.64. The stock recorded a trading volume of 2,460,747 shares, which was below its three months average volume of 2,702,706 shares. In the last year, Amicus Therapeutics' shares have traded in a range of 8.27 - 17.62. The share price has gained 40.75% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $10.66 is below its 200-day moving average of $12.20. Shares of Amicus Therapeutics have gained roughly 25.43 percent in the past month and are up 21.5 percent year-to-date.

Access The Market Wealth's Amicus Therapeutics, Inc. Research Report:
https://marketwealthreport.com/report/FOLD/

On Friday, shares of ACADIA Pharmaceuticals recorded a trading volume of 1,765,069 shares, which was below the three months average volume of 2,326,155 shares. The stock ended the day 4.48% higher at $22.61. The share price has fallen 31.46% from its 52 week high with a 52 week trading range of 12.77 - 32.99. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $18.42 is above its 200-day moving average of $17.93. Shares of ACADIA Pharmaceuticals have gained roughly 46.34 percent in the past month and are up 39.83 percent year-to-date.

Access The Market Wealth's ACADIA Pharmaceuticals Inc. ResearchReport:
https://marketwealthreport.com/report/ACAD/

Our Actionable Research on Amicus Therapeutics, Inc. (NYSE:FOLD) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) can be downloaded free of charge at The Market Wealth Report.

The Market Wealth Report

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Wealth Report has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketWealthReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketWealthReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketwealthreport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Wealth Report, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketwealthreport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Market Wealth Report